These nanoparticles remodel the tumor microenvironment by promoting the polarization of macrophages towards an M1 phenotype and enhancing the infiltration of cytotoxic T lymphocytes, thereby strengthening anti-PD-L1-mediated immunotherapy [137]. The gene discussed is CD274; the disease is neoplasm.